Key result
HPI-guided hypotension reduction is linked to greater hemodynamic treatment intensity.
Why the study?
Existing HPI trials may effectively compare two MAP-treatment thresholds with differing treatment intensity, but meta-analyses have not consistently reported treatment intensity differences.
Is the reduction of hypotension in HPI-guided management associated with greater treatment intensity compared to standard care?
Systematic Review (n=2,342)
Is the reduction of hypotension in HPI-guided management associated with greater treatment intensity compared to standard care?
Successful reduction of hypotension in HPI trials is generally accompanied by more intensive hemodynamic treatment, suggesting the benefit may be driven by treatment intensity rather than the prediction index itself.
Hypotension reduction in HPI trials tracks with intensified treatment; challenges attribution of benefit to the index itself and supports intensity-matched trials.
BACKGROUND: The Hypotension Prediction Index (HPI) is developed for proactive prevention of hypotension and existing meta-analyses report reduced hypotension with HPI-guided management in comparison with a strategy based on MAP alerts of 65 mmHg. Still, validation studies suggest that HPI does not outperform simple mean arterial pressure (MAP)-based predictions and report that HPI alerts appear when MAP is ~70-75 mmHg. Existing HPI trials may therefore effectively compare two MAP-treatment thresholds that could be accompanied by different treatment intensity. However, meta-analyses do not consistently report treatment intensity differences. We hypothesized that reductions in hypotension are associated with greater treatment intensity. METHODS: Randomized trials evaluating HPI-guided hypotension prevention were identified from existing systematic reviews and citation tracking. Eligible trials were assessed for (1) statistically significant reduction in the primary hypotension outcome and (2) statistically significant increases in any hemodynamic treatment (fluids, vasopressors, or inotropes) in the HPI intervention group. We examined the association between hypotension reduction and treatment intensity using 2×2 tabulation and Fisher's exact test. Furthermore, for trials reporting time-weighted average (TWA) of MAP< 65 mmHg, we calculated the correlation between the TWA difference and treatment intensity categories (lower, neutral, or increased). RESULTS: Twenty randomized trials (2342 patients) were identified of which 18 reported both hypotension and treatment outcomes. Among 13 trials demonstrating hypotension reduction, 9 (69%) reported significantly greater treatment intensity in the HPI intervention group. In contrast, none of the five trials that failed to reduce hypotension reported increased treatment intensity. Reduction of hypotension was significantly associated with greater treatment intensity (p = 0.029). TWA differences were significantly correlated with treatment intensity (p < 0.001). CONCLUSIONS: Across randomized HPI trials, reduced hypotension was frequently accompanied by increased treatment intensity. These associations suggest that successful reduction of hypotension in HPI trials generally occurred together with more intensive hemodynamic treatment.
No takes yet. Share an insight, caveat, or question.
Vistisen et al. (2026) conducted a systematic review in Hypotension (n=2,342). Hypotension Prediction Index (HPI)-guided management vs. MAP alerts of 65 mmHg was evaluated on Association between hypotension reduction and treatment intensity (p=0.029). Across randomized trials, successful reduction of hypotension using HPI-guided management was significantly associated with greater hemodynamic treatment intensity (p=0.029).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: